EC-specific Scube2-knockout (EC-KO) and SP.B1 (anti-SCUBE2 monoclonal antibody) inhibited vascular tumor density and xenograft tumor growth, increased apoptosis, and reduced tumor-cell proliferation in a mouse model. This evidence concerns the gene SCUBE2 and neoplasm.